News Snapshot:
Author Reporter Comment(0) Mexico aims to conduct late-stage clinical trials for COVID-19 vaccines in development by U.S. and Chinese companies, two of which might base some of their vaccine production in the country, the foreign ministry said on Tuesday. Mexico has signed memorandums of understanding with Johnson & Johnson, along with Chinese companies CanSino Biologics Inc and Walvax Biotechnology Co Ltd, Foreign Minister Marcelo Ebrard said at news conference. Ebrard said the trials would start between September and January, depending on approval from Mexico’s food and drug agency, reports Reuters. He said the goal to secure access to the drugs...
